• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪注射液及其成分对乳腺癌细胞系增殖及Akt磷酸化的影响

[Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines].

作者信息

Deng Ying, Chen Hong-feng

机构信息

Department of Breast Surgery, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.

出版信息

Zhong Xi Yi Jie He Xue Bao. 2009 Dec;7(12):1174-80. doi: 10.3736/jcim20091216.

DOI:10.3736/jcim20091216
PMID:20015441
Abstract

OBJECTIVE

To observe the effects of Astragalus injection, astragaloside IV and formononetin on proliferation and Akt phosphorylation of basal-like human breast carcinoma cell lines MDA-MB-468 and MDA-MB-231.

METHODS

The effects of different concentrations of Astragalus injection, astragaloside IV and formononetin on proliferation of breast cancer cell lines were assayed by methyl thiazolyl tetrazolium (MTT) assay, and their effects on phospho-Akt were assayed by in-cell Western blot method.

RESULTS

The results of the MTT assay showed that the best concentrations of Astragalus injection, astragaloside IV, formononetin and astragaloside IV plus formononetin were 1 g/mL, 80 microg/mL, 40 microg/mL and 10 microg/mL plus 40 microg/mL respectively. After 1- or 2-day culture, Astragalus injection, astragaloside IV, formononetin and astragaloside IV plus formononetin decreased the expressions of p-Akt (Thr 308) and p-Akt (Ser 473) in MDA-MB-468 cells. Formononetin and astragaloside IV plus formononetin down-regulated the expression of p-Akt (Thr 308) protein in MDA-MB-231 cells after 1- and 2-day culture, but had no effects on the expression of p-Akt (Ser 473) protein in MDA-MB-231 cells.

CONCLUSION

Astragalus injection, astragaloside IV and formononetin can inhibit proliferation of breast cancer cell lines MDA-MB-468 and MDA-MB-231, and the antiproliferation effects vary according to their concentrations. And the antiproliferation mechanisms may be related to their down-regulation effects on Akt phosphorylation.

摘要

目的

观察黄芪注射液、黄芪甲苷IV和芒柄花黄素对基底样人乳腺癌细胞系MDA-MB-468和MDA-MB-231增殖及Akt磷酸化的影响。

方法

采用甲基噻唑基四氮唑(MTT)法检测不同浓度的黄芪注射液、黄芪甲苷IV和芒柄花黄素对乳腺癌细胞系增殖的影响,采用细胞内Western印迹法检测其对磷酸化Akt的影响。

结果

MTT法结果显示,黄芪注射液、黄芪甲苷IV、芒柄花黄素及黄芪甲苷IV加芒柄花黄素的最佳浓度分别为1 g/mL、80 μg/mL、40 μg/mL和10 μg/mL加40 μg/mL。培养1天或2天后,黄芪注射液、黄芪甲苷IV、芒柄花黄素及黄芪甲苷IV加芒柄花黄素降低了MDA-MB-468细胞中p-Akt(苏氨酸308)和p-Akt(丝氨酸473)的表达。培养1天和2天后,芒柄花黄素及黄芪甲苷IV加芒柄花黄素下调了MDA-MB-231细胞中p-Akt(苏氨酸308)蛋白的表达,但对MDA-MB-231细胞中p-Akt(丝氨酸473)蛋白的表达无影响。

结论

黄芪注射液、黄芪甲苷IV和芒柄花黄素可抑制乳腺癌细胞系MDA-MB-468和MDA-MB-231的增殖,并根据其浓度不同产生不同的抗增殖作用。其抗增殖机制可能与其下调Akt磷酸化有关。

相似文献

1
[Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines].黄芪注射液及其成分对乳腺癌细胞系增殖及Akt磷酸化的影响
Zhong Xi Yi Jie He Xue Bao. 2009 Dec;7(12):1174-80. doi: 10.3736/jcim20091216.
2
[Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line].黄芪多糖对基底样乳腺癌细胞系增殖及Akt磷酸化的影响
Zhong Xi Yi Jie He Xue Bao. 2011 Dec;9(12):1339-46. doi: 10.3736/jcim20111210.
3
Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.大豆苷元通过PI3K/AKT信号通路抑制基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9),从而抑制MDA-MB-231和4T1乳腺癌细胞的迁移和侵袭。
Horm Metab Res. 2014 Oct;46(11):753-60. doi: 10.1055/s-0034-1376977. Epub 2014 Jun 30.
4
Formononetin-induced apoptosis by activation of Ras/p38 mitogen-activated protein kinase in estrogen receptor-positive human breast cancer cells.芒柄花素通过激活 Ras/p38 丝裂原活化蛋白激酶诱导雌激素受体阳性人乳腺癌细胞凋亡。
Horm Metab Res. 2012 Dec;44(13):943-8. doi: 10.1055/s-0032-1321818. Epub 2012 Jul 24.
5
Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.芒柄花素通过 IGF1/PI3K/Akt 通路在体外和体内诱导人乳腺癌细胞周期停滞。
Horm Metab Res. 2011 Sep;43(10):681-6. doi: 10.1055/s-0031-1286306. Epub 2011 Sep 19.
6
[Effects of platycodin D in combination with different active ingredients of Chinese herbs on proliferation and invasion of 4T1 and MDA-MB-231 breast cancer cell lines].桔梗皂苷D与中药不同活性成分联合应用对4T1和MDA-MB-231乳腺癌细胞系增殖和侵袭的影响
Zhong Xi Yi Jie He Xue Bao. 2012 Jan;10(1):67-75. doi: 10.3736/jcim20120111.
7
Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.黄芪甲苷通过抑制 Vav3 介导的 Rac1/MAPK 信号通路抑制乳腺癌细胞侵袭。
Int Immunopharmacol. 2017 Jan;42:195-202. doi: 10.1016/j.intimp.2016.10.001. Epub 2016 Dec 5.
8
Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN.大豆苷元通过调控miR-21和PTEN抑制人膀胱癌细胞的增殖和侵袭能力。
Food Funct. 2017 Mar 22;8(3):1061-1066. doi: 10.1039/c6fo01535b.
9
[Effects of Astragalus injection on proliferation of basal-like breast cancer cell line MDA-MB-468].黄芪注射液对基底样乳腺癌细胞系MDA-MB-468增殖的影响
Zhong Xi Yi Jie He Xue Bao. 2008 Apr;6(4):399-404. doi: 10.3736/jcim20080414.
10
[Inhibiting effects of three components of Astragalus membranaceus on oxidative stress in Chang Liver cells].[黄芪三种成分对Chang肝细胞氧化应激的抑制作用]
Zhongguo Zhong Yao Za Zhi. 2015 Jan;40(2):318-23.

引用本文的文献

1
Based on network pharmacology and molecular docking to predict the mechanism of Huangqi in the treatment of castration-resistant prostate cancer.基于网络药理学和分子对接预测黄芪治疗去势抵抗性前列腺癌的作用机制。
PLoS One. 2022 May 20;17(5):e0263291. doi: 10.1371/journal.pone.0263291. eCollection 2022.
2
Inhibition or Reversal of the Epithelial-Mesenchymal Transition in Gastric Cancer: Pharmacological Approaches.胃癌中上皮-间质转化的抑制或逆转:药理学方法。
Int J Mol Sci. 2020 Dec 29;22(1):277. doi: 10.3390/ijms22010277.
3
Reducing postsurgical exudate in breast cancer patients by using San Huang decoction to ameliorate inflammatory status: a prospective clinical trial.
运用三黄汤改善炎症状态以减少乳腺癌患者术后渗出液:一项前瞻性临床试验
Curr Oncol. 2018 Dec;25(6):e507-e515. doi: 10.3747/co.25.4108. Epub 2018 Dec 1.
4
Chinese Herbal Medicine as an Adjunctive Therapy Ameliorated the Incidence of Chronic Hepatitis in Patients with Breast Cancer: A Nationwide Population-Based Cohort Study.中药作为辅助疗法改善乳腺癌患者慢性肝炎的发生率:一项基于全国人群的队列研究
Evid Based Complement Alternat Med. 2017;2017:1052976. doi: 10.1155/2017/1052976. Epub 2017 Oct 30.
5
A systematic review of anticancer effects of radix astragali.黄芪抗癌作用的系统评价
Chin J Integr Med. 2016 Mar;22(3):225-36. doi: 10.1007/s11655-015-2324-x. Epub 2015 Dec 7.
6
Yiqi formula enhances the antitumor effects of erlotinib for treatment of triple-negative breast cancer xenografts.益气方增强厄洛替尼对三阴性乳腺癌异种移植瘤的抗肿瘤作用。
Evid Based Complement Alternat Med. 2014;2014:628712. doi: 10.1155/2014/628712. Epub 2014 Oct 19.
7
A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease.采用系统生物学方法揭示草药中的药物协同作用及其在心血管疾病中的应用。
Evid Based Complement Alternat Med. 2012;2012:519031. doi: 10.1155/2012/519031. Epub 2012 Nov 29.